LIFE — aTyr Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- $106.67m
- $10.24m
- $0.35m
- 26
- 13
- 65
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 31.1 | 31.7 | 108 | 66.1 | 98.2 |
Net Total Receivables | — | 2.04 | 0.435 | 11.8 | 2.44 |
Prepaid Expenses | |||||
Total Current Assets | 31.9 | 35.5 | 114 | 80.9 | 103 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.09 | 2.98 | 1.81 | 11.6 | 14 |
Other Long Term Assets | |||||
Total Assets | 36.2 | 38.7 | 116 | 95.8 | 121 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.9 | 5.86 | 6.01 | 13.9 | 16.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 15 | 7.08 | 6.24 | 24.3 | 30 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 21.2 | 31.6 | 109 | 71.5 | 90.7 |
Total Liabilities & Shareholders' Equity | 36.2 | 38.7 | 116 | 95.8 | 121 |
Total Common Shares Outstanding |